MoneyWorks4Me

Oxygenta Pharma - Quaterly Results

24 May 2026 Evaluate
The quarter ended March 2026 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 496.14 millions.The Net Loss for the quarter ended March 2026 is Rs. -17.04 millions as compared to Net Loss of Rs. -21.51 millions of corresponding quarter ended March 2025 Operating profit Margin for the quarter ended March 2026 improved to 2.87% as compared to -19.05% of corresponding quarter ended March 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 496.14 494.67 0.30 1129.82 1092.99 3.37 1129.82 1092.99 3.37
Other Income 1.73 0.49 253.06 2.86 13.09 -78.15 2.86 13.09 -78.15
PBIDT 2.87 -19.05 -115.07 -150.80 -87.76 71.83 -150.80 -87.76 71.83
Interest 18.08 21.28 -15.04 47.77 19.61 143.60 47.77 19.61 143.60
PBDT -15.21 -40.33 -62.29 -198.57 -107.37 84.94 -198.57 -107.37 84.94
Depreciation -2.41 -2.34 2.99 23.23 36.14 -35.72 23.23 36.14 -35.72
PBT -12.80 -37.99 -66.31 -221.80 -143.51 54.55 -221.80 -143.51 54.55
TAX 4.24 -16.48 -125.73 -46.09 -40.53 13.72 -46.09 -40.53 13.72
Deferred Tax 4.24 -18.08 -123.45 -46.09 -42.13 9.40 -46.09 -42.13 9.40
PAT -17.04 -21.51 -20.78 -175.71 -102.98 70.63 -175.71 -102.98 70.63
Equity 369.84 369.84 0.00 369.84 369.84 0.00 369.84 369.84 0.00
PBIDTM(%) 0.58 -3.85 -115.02 -13.35 -8.03 66.23 -13.35 -8.03 66.23
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..